UNC Lineberger Comprehensive Cancer Center

UNC Lineberger researchers have demonstrated that combining two immunotherapy drugs with a targeted therapy drug proved effective in treating the most common form of metastatic colorectal cancer. The study’s findings are published in JCO Oncology Advances.

UNC Lineberger researchers and colleagues report their findings that an experimental immunotherapy using chimeric antigen receptor macrophages (CAR-M) is safe and helps activate the body’s immune system against certain solid cancers.

UNC Lineberger researchers have demonstrated a faster, more cost-effective approach to analyzing the genetic makeup of pediatric acute leukemia. Determining a cancer’s genomic classification is critical to developing a more effective treatment plan tailored to a patient’s tumor.

Big congratulations to UNC Lineberger's Angela Smith, MD, MS, on her induction into the Order of the Golden Fleece, University of North Carolina at Chapel Hill's oldest and most prestigious honor society. Smith is the associate dean for Faculty Affairs and Leadership Development, and the department of urology’s vice chair of academic affairs and a professor of urology. She is also a member of the urologic oncology team at UNC Lineberger, where she treats GU malignancies, including bladder, prostate and kidney cancer.

Colorectal cancer rates are rising among adults under 45, challenging previous age assumptions. UNC Lineberger's Ashwin Somasundaram, MD, discusses potential factors and emphasizes earlier screening and awareness. More here: https://lnkd.in/eWHRpH2R

The Foundation for the Accreditation of Cellular Therapy awarded accreditation without any deficiency citations to UNC Lineberger’s Advanced Cellular Therapeutics Facility. “Earning FACT accreditation is a major milestone for any manufacturing facility and underscores our commitment to the highest standards in cellular therapy,” said UNC Lineberger's Jonathan Serody, MD. https://lnkd.in/e_D3k2YH

The Boys & Girls Club of Durham and Orange Counties partnered with UNC Lineberger to bring predoctoral students, postdoctoral fellows and faculty members to present lay language scientific talks. 

The standard of care for patients diagnosed with glioblastoma has remained unchanged since 2005. Presentations at the symposium highlighted the continued need for brain tumor research support to one day develop a cure for this deadly disease. 

UNC Research is Ashley Leak Bryant. Read about her contributions to research at Carolina: https://go.unc.edu/k7CXx Ashley helps to build and sustain the oncology care workforce. Her research focuses on designing and testing palliative and supportive care interventions for older adults with cancer and their care partners. Her research is funded by grants from the National Institutes of Health. This funding supports vital research, helping the people of North Carolina and beyond. Ashley has been a Tar Heel for 20 years and is a fellow North Carolinian. #UNCResearchIsNC #oncology #medicine #UNC #NorthCarolina #career #community . University of North Carolina at Chapel Hill Ashley Leak Bryant PhD, RN, OCN, FAAN UNC Chapel Hill School of Nursing UNC Lineberger Comprehensive Cancer Center

🗳️ Attention physicians! The U.S. News and World Report best hospital survey is still open in Doximity. UNC Lineberger executive director and chief of oncology clinical services at UNC Health, Robert Ferris, MD, PhD, shares why your vote matters and how UNC Hospitals continues to lead in oncology/hematology patient care and research.